Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04297332 · ClinicalTrials.gov registry record · NA
Episodic Future Thinking and Future Thinking Priming for Smoking Cessation
A NA study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04297332: Clinical Trial NA study, sponsored by Roswell Park Cancer Institute.
NCT04297332 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04297332, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This trial studies the main and interactive effects of episodic future thinking and future thinking priming tasks on helping participants to quit smoking. Episodic future thinking and future thinking priming tasks may decrease delay discounting rates and reduce relapse to smoking and help participants quit smoking.
Primary Outcome
Assessed with the 5-Trial Adjusting Delay Discounting.
Interventions
- BEHAVIORAL Behavioral Intervention
- OTHER Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2023-12-28 |
| Phase | NA |
Why NCT04297332 stopped before completion
NCT04297332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral Intervention is the first listed.
NCT04297332 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04297332 about?
NCT04297332 is a clinical study titled "Episodic Future Thinking and Future Thinking Priming for Smoking Cessation". This trial studies the main and interactive effects of episodic future thinking and future thinking priming tasks on helping participants to quit smoking. Episodic future thinking and future thinking priming tasks may decrease delay discounting rates and reduce relapse to smoking and help participan...
What is the current status of trial NCT04297332?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2020-01-01. Estimated completion is 2023-12-28.
What interventions are being tested in trial NCT04297332?
The interventions under investigation include: Behavioral Intervention (BEHAVIORAL), Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT04297332?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04297332's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI